# FDA recall D-0659-2024

> **Rubicon Research Private Limited** · Class III · drug recall initiated 2024-08-24.

## Product

AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India  NDC 72888-047-01

## Reason for recall

Discoloration

## Distribution

Nationwide in the US

## Key facts

- **Recall number:** D-0659-2024
- **Recalling firm:** Rubicon Research Private Limited
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-08-24
- **Report date:** 2024-09-25

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Ambarnath, India

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0659-2024

## Citation

> AI Analytics. FDA recall D-0659-2024. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0659-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*